Recombinant multi-species NAT8L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAT8L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a single-pass membrane protein, which contains a conserved sequence of the GCN5 or NAT superfamily of N-acetyltransferases and is a member of the N-acyltransferase (NAT) superfamily. This protein is a neuron-specific protein and is the N-acetylaspartate (NAA) biosynthetic enzyme, catalyzing the NAA synthesis from L-aspartate and acetyl-CoA. NAA is a major storage and transport form of acetyl coenzyme A specific to the nervous system. The gene mutation results in primary NAA deficiency (hypoacetylaspartia). [provided by RefSeq, Dec 2010]
The Alternative Names of target: 1110038O08Rik,CML3,Camello-like protein 3,N-acetylaspartate synthetase,N-acetyltransferase 8-like protein,NAA synthetase,NACED,NAT8-LIKE,NAT8L,Nat8l,RGD1305719,Shati

Target products collectionGo to NAT8L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1236-Ag-1/ GM-Tg-hg-IP1236-Ag-2 Human NAT8L protein Human
GM-Tg-rg-IP1236-Ag-1/ GM-Tg-rg-IP1236-Ag-2 Rat NAT8L protein Rat
GM-Tg-mg-IP1236-Ag-1/ GM-Tg-mg-IP1236-Ag-2 Mouse NAT8L protein Mouse
GM-Tg-cynog-IP1236-Ag-1/ GM-Tg-cynog-IP1236-Ag-2 Cynomolgus/Rhesus macaque NAT8L protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1236-Ag-1/ GM-Tg-felg-IP1236-Ag-2 Feline NAT8L protein Feline
GM-Tg-cang-IP1236-Ag-1/ GM-Tg-cang-IP1236-Ag-2 Canine NAT8L protein Canine
GM-Tg-bovg-IP1236-Ag-1/ GM-Tg-bovg-IP1236-Ag-2 Bovine NAT8L protein Bovine
GM-Tg-equg-IP1236-Ag-1/ GM-Tg-equg-IP1236-Ag-2 Equine NAT8L protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1236-Ag-1/ GM-Tg-hg-IP1236-Ag-2; GM-Tg-rg-IP1236-Ag-1/ GM-Tg-rg-IP1236-Ag-2;
GM-Tg-mg-IP1236-Ag-1/ GM-Tg-mg-IP1236-Ag-2; GM-Tg-cynog-IP1236-Ag-1/ GM-Tg-cynog-IP1236-Ag-2;
GM-Tg-felg-IP1236-Ag-1/ GM-Tg-felg-IP1236-Ag-2; GM-Tg-cang-IP1236-Ag-1/ GM-Tg-cang-IP1236-Ag-2;
GM-Tg-bovg-IP1236-Ag-1/ GM-Tg-bovg-IP1236-Ag-2; GM-Tg-equg-IP1236-Ag-1/ GM-Tg-equg-IP1236-Ag-2
Products Name NAT8L protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NAT8L
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAT8L protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.